These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

69 related articles for article (PubMed ID: 16287588)

  • 1. Early oligoarthritis.
    Marzo-Ortega H; Cawkwell L; Green MJ
    Rheum Dis Clin North Am; 2005 Nov; 31(4):627-39. PubMed ID: 16287588
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Juvenile psoriatic arthritis: longterm outcome and differentiation from other subtypes of juvenile idiopathic arthritis.
    Flatø B; Lien G; Smerdel-Ramoya A; Vinje O
    J Rheumatol; 2009 Mar; 36(3):642-50. PubMed ID: 19208605
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Conventional disease-modifying antirheumatic drugs in early arthritis.
    Sokka T; Hannonen P; Möttönen T
    Rheum Dis Clin North Am; 2005 Nov; 31(4):729-44. PubMed ID: 16287594
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy of roxithromycin in adult patients with rheumatoid arthritis who had not received disease-modifying antirheumatic drugs: a 3-month, randomized, double-blind, placebo-controlled trial.
    Ogrendik M
    Clin Ther; 2009 Aug; 31(8):1754-64. PubMed ID: 19808134
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Early inflammatory arthritis versus rheumatoid arthritis.
    Finckh A
    Curr Opin Rheumatol; 2009 Mar; 21(2):118-23. PubMed ID: 19339921
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Response-driven combination therapy with conventional disease-modifying antirheumatic drugs can achieve high response rates in early rheumatoid arthritis with minimal glucocorticoid and nonsteroidal anti-inflammatory drug use.
    Proudman SM; Keen HI; Stamp LK; Lee AT; Goldblatt F; Ayres OC; Rischmueller M; James MJ; Hill CL; Caughey GE; Cleland LG
    Semin Arthritis Rheum; 2007 Oct; 37(2):99-111. PubMed ID: 17391739
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assessment and management of rheumatoid arthritis.
    Haraoui B
    J Rheumatol Suppl; 2009 Jun; 82():2-10. PubMed ID: 19509324
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Accuracy of Wallace criteria for clinical remission in juvenile idiopathic arthritis: a cohort study of 761 consecutive cases.
    Lurati A; Salmaso A; Gerloni V; Gattinara M; Fantini F
    J Rheumatol; 2009 Jul; 36(7):1532-5. PubMed ID: 19487265
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Early rheumatoid arthritis -- is there a window of opportunity?
    Cush JJ
    J Rheumatol Suppl; 2007 Nov; 80():1-7. PubMed ID: 17985417
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum matrix metalloproteinases and tissue inhibitors of metalloproteinases in patients with early rheumatoid arthritis.
    Fiedorczyk M; Klimiuk PA; Sierakowski S; Gindzienska-Sieskiewicz E; Chwiecko J
    J Rheumatol; 2006 Aug; 33(8):1523-9. PubMed ID: 16881109
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A prediction rule for disease outcome in patients with recent-onset undifferentiated arthritis: how to guide individual treatment decisions.
    van der Helm-van Mil AH; le Cessie S; van Dongen H; Breedveld FC; Toes RE; Huizinga TW
    Arthritis Rheum; 2007 Feb; 56(2):433-40. PubMed ID: 17265478
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A randomized controlled trial of early intervention with intraarticular corticosteroids followed by sulfasalazine versus conservative treatment in early oligoarthritis.
    Marzo-Ortega H; Green MJ; Keenan AM; Wakefield RJ; Proudman S; Emery P
    Arthritis Rheum; 2007 Feb; 57(1):154-60. PubMed ID: 17266089
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The LUNDEX, a new index of drug efficacy in clinical practice: results of a five-year observational study of treatment with infliximab and etanercept among rheumatoid arthritis patients in southern Sweden.
    Kristensen LE; Saxne T; Geborek P
    Arthritis Rheum; 2006 Feb; 54(2):600-6. PubMed ID: 16447237
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Drug management of early rheumatoid arthritis - 2008.
    Sokka T; Mäkinen H
    Best Pract Res Clin Rheumatol; 2009 Feb; 23(1):93-102. PubMed ID: 19233049
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development and validation of a preliminary definition of minimal disease activity in patients with juvenile idiopathic arthritis.
    Magni-Manzoni S; Ruperto N; Pistorio A; Sala E; Solari N; Palmisani E; Cugno C; Bozzola E; Martini A; Ravelli A
    Arthritis Rheum; 2008 Aug; 59(8):1120-7. PubMed ID: 18668599
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Are biologics more effective than classical disease-modifying antirheumatic drugs?
    Nurmohamed MT; Dijkmans BA
    Arthritis Res Ther; 2008; 10(5):118. PubMed ID: 18828888
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Five-year outcome of a primary-care-based inception cohort of patients with inflammatory polyarthritis plus psoriasis.
    Morgan C; Lunt M; Bunn D; Scott DG; Symmons DP
    Rheumatology (Oxford); 2007 Dec; 46(12):1819-23. PubMed ID: 18032539
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Progression in early rheumatoid arthritis.
    Combe B
    Best Pract Res Clin Rheumatol; 2009 Feb; 23(1):59-69. PubMed ID: 19233046
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Predictors of response to anti-TNF-alpha therapy among patients with rheumatoid arthritis: results from the British Society for Rheumatology Biologics Register.
    Hyrich KL; Watson KD; Silman AJ; Symmons DP;
    Rheumatology (Oxford); 2006 Dec; 45(12):1558-65. PubMed ID: 16705046
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biologics in early rheumatoid arthritis.
    de Vries-Bouwstra JK; Dijkmans BA; Breedveld FC
    Rheum Dis Clin North Am; 2005 Nov; 31(4):745-62. PubMed ID: 16287595
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.